Aytu BioPharma, Inc.AYTUNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank73
3Y CAGR-17.7%
5Y CAGR-6.9%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-17.7%/yr
vs +38.1%/yr prior
5Y CAGR
-6.9%/yr
Recent deceleration
Acceleration
-55.8pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$39.09M+2.1%
2025$38.28M-8.9%
2024$42.04M-40.0%
2023$70.08M+0.3%
2022$69.88M+25.2%
2021$55.81M+79.7%
2020$31.06M+61.4%
2019$19.24M+8.5%
2018$17.73M+0.7%
2017$17.61M-